Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...
Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Either we get ahead of this crisis or watch a generation of Americans be swept into the devastating grip of disease.
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
ICA to screen Independent documentary amid unprecedented cuts to global HIV/AIDs response - To mark World AIDS Day, the ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results